Microalbuminuria

Overview

Microalbuminuria is the earliest detectable stage of albumin leak — a tiny amount of albumin in the urine (an ACR of 30–300 mg/g) that is too small to be picked up by a standard urine dipstick but is found on a laboratory urine albumin-to-creatinine ratio. It is important because it appears years before blood tests of kidney function change, which makes it the key screening signal for early kidney damage in diabetes and high blood pressure. Catching it at this stage is when the most can be done to slow or halt progression. This page focuses on the early-stage screening concept; the broader topic of albumin in the urine is covered on the Albuminuria page, which links here.

Why it matters as a screening signal

Because microalbuminuria develops silently and reversibly in its early phase, it is the test that turns kidney care from reactive to preventive. In diabetes, annual urine ACR screening is recommended from the time of diagnosis in type 2 diabetes and from five years after diagnosis in type 1 diabetes. In high blood pressure, urine ACR is checked at diagnosis and periodically thereafter. A confirmed microalbuminuria result triggers protective treatment even when kidney function looks normal.

Who should be screened

• Everyone with type 2 diabetes, annually from diagnosis.
• People with type 1 diabetes, annually from five years after diagnosis.
• People with high blood pressure, at diagnosis and periodically.
• People with a family history of kidney disease or known cardiovascular risk.

Evaluation and investigations

A single ACR result in the microalbuminuria range is confirmed by repeating the test on two further occasions, since exercise, fever, infection or illness can cause a temporary rise. Confirmed microalbuminuria prompts a full kidney assessment — creatinine and eGFR, blood pressure, blood sugar or HbA1c and a lipid profile, and an ultrasound of the kidneys.

Management overview

Management at this early stage is highly effective: tight blood pressure and sugar control, specific medicines that reduce the albumin leak and protect the filters, salt moderation, and avoidance of kidney-irritating medicines. With these measures, microalbuminuria can often be reduced or even reversed, and progression to overt kidney disease slowed substantially.

Follow-up and monitoring

The ACR is re-checked at regular intervals to confirm the response to treatment. See Kidney Health Monitoring.

Warning signs — seek prompt care

• A rapid increase in albumin leak with swelling.
• Microalbuminuria with rising creatinine or falling eGFR.
• Foamy urine with swelling and rising blood pressure.

How we help

Dr. Nayak uses urine ACR screening to catch kidney leak at its earliest, reversible stage, and starts protective treatment before function is lost. Consultations are available in-clinic in Bhubaneswar and over teleconsultation.

Related conditions and patient concerns

• Albuminuria
• Protein in Urine
• Urine Albumin-to-Creatinine Ratio (ACR)
• Diabetic Kidney Disease
• Kidney Health Monitoring
• Diabetes & Metabolic Health
• Hypertension & Cardiovascular Risk